United States Army Medical Research Institute of Infectious Diseases KYLE MELLING.

Slides:



Advertisements
Similar presentations
Local Public Health System Assessment using the NPHPSP Local Instrument Essential Service 2 Diagnose and Investigate Health Problems and Health Hazards.
Advertisements

OVERVIEW OF INDUSTRIAL HYGIENE UNIVERSITY OF HOUSTON – DOWNTOWN CAMPUS.
First National Course on Public Health Emergency Management 12 – 23 March Muscat, Oman BCRN Management Perspectives Nasser H. Al-Azri BSc, MD, MRCS(A&E),
The Laboratory Response Network
Bioterrorism: Changing Priorities in Medical Training and Research Art Anderson MD Colonel US Army Medical Corps Director, Office of Human Use and Ethics,
DEFENSE SUPPORT OF CIVIL AUTHORITIES (DSCA)
Future International Environmental Security Issues and Potential Military Requirements over the period of 2010 to for the U.S. Army Environmental.
BIOLOGICAL HAZARDS RISK ASSESSMENT
1 OSHA FEDERAL OCCUPATIONAL SAFETY AND HEALTH ACT (OSHA) OF 1970 George Mason University College of Nursing and Health Science Regulatory Requirements.
1 Recent Bioterrorism Legislation Madelyn Miller August 2003.
The Laboratory Response Network
The Select Agent Laboratory: at the intersection of research, preparedness and safety Nancy Connell,PhD Professor and Vice-chair for Research Department.
Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.
U.S. Department of Defense Drug and Vaccine Development
ADP 1 The Army.
Laboratory Response Network Spokane Regional Health District.
Vice Chancellor for RESEARCH Office of the Global Health is America’s Health and National Security Samuel L. Stanley, Jr., M.D. Paul Rogers Global Health.
Association of Public Health Laboratories National Center for Public Health Laboratory Leadership Cohort IV.
FOOD SAFETY LEGISLATION Food Safety legislation is designed to protect consumers from illness and harm.
FLC MAR meeting 15 September 2009 Medical Technology Transfer Product Development and Commercialization Thru Partnering and Licensing De-Mystifying Technology.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Copyright Medical Group Management Association. All rights reserved. Name, credentials Organization Date Preparing Your Office Practice for Disaster.
CTTSO Overview John Morgan, Deputy Director for Science and Technology, CTTSO September 2010.
GWS SMS INTRODUCTION MSM Manual. 3. MISSION STATEMENT AND CORE VALUES OF THE COMPANY  MISSION  Our Mission is to provide expertise in the fields of.
CITI Biosafety Training Information Project
Best Practice Guideline for the Workplace During Pandemic Influenza Occupational Health and Safety Employment Standards.
1 Exotic Disease Response Knowledge of Exotic Animal Diseases and Response Measures.
Safety. Four Simple Questions What are the hazards? What are the hazards? What are the worst things that could happen? What are the worst things that.
Critical Infrastructure Protection Overview Building a safer, more secure, more resilient America The National Infrastructure Protection Plan, released.
“History is a set of lies agreed upon.” Napoleon Bonaparte.
Biosafety/ Biosecurity in Georgia Lela Bakanidze, Ph.D. National Center for Disease Control and Medical Statistics of Georgia Scientific Networking and.
Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Approved: 9 Jun DoD Leader’s Briefing: Force Health Protection Against Anthrax.
STRATEGIC PLAN DEPUTY CHIEF OF STAFF FOR PERSONNEL, INFRASTRUCTURE AND LOGISTICS U.S. ARMY TRAINING AND DOCTRINE COMMAND OCTOBER 2005.
Material Control & Accountability
Public Health Issues Associated with Biological and Chemical Terrorism Scott Lillibridge, MD Director Bioterrorism Preparedness and Response Activity National.
Governor’s Taskforce for Pandemic Influenza Preparedness Issue Paper Credible and Effective Decision-making Workgroup Members Robert Rolfs, State Epidemiologist,
Center for Biologics Evaluation and Research Carolyn A. Wilson, Ph.D. Associate Director for Research Applying Regulatory Science to Advance Development.
June 30 & July 1, 2008Fort Detrick Sustainability Workshop1 Welcome to Fort Detrick Sustainability Workshop No. 1 June 30 and July 1, 2008 at Frederick.
PHEP Capabilities John Erickson, Special Assistant Washington State Department of Health
Biosecurity at CDC pre & post 9/11 Jonathan Y. Richmond, PhD Director Office of Health and Safety CDC, Atlanta.
OVERVIEW - Intro POD OVERVIEW Point of Dispensing (POD) Overview for Communities.
Infinite, eternal and unchangeable In holiness. The symptoms of smallpox Symptoms of smallpox.
The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.
One Healthcare System’s Response to the Chaos Swedish Health Services Swedish Medical Centers: Ballard, Cherry Hill, Edmonds, First Hill, & Issaquah Ambulatory.
Centers for Disease Control and Prevention (CDC): Fighting Diseases Worldwide Presented by: Angela Permon Resident Scientist Snook ISD Presented by: Angela.
1 MTEC Overview for SMARTPROC 2015 Scott Savoie Vice President, Corporate Contracts, SCRA 20 November 2015.
Emerging and Re-emerging Infectious Diseases Challenges and Opportunities for Militaries LTC (Dr) Vernon Lee MBBS, PhD, FAMS, MPH,MBA Singapore Armed Forces.
“28,424 cases of Ebola and still counting—what have we learned
Thomas S. Bundt, PhD., FACHE COL, MS Commander, USAMRIID
Developing Effective Partnerships with State Government CDC Public Health Preparedness Conference 2005 Marsha Morien, MSBA, FACHE Nebraska Center for Rural.
Food Safety, Work Place Safety, and Emergency Preparedness National Food Service Management Institute The University of Mississippi 1.
UNDERSTANDING BIOTERRORISM: Tara O’Toole, MD, MPH The United States Conference of Mayors Mayors Emergency, Safety & Security Summit October 24, 2001.
1 Literature Review Digital government and Bio- defense: what they are, major issues, major IT issues, and who work on those issues Dai Cui.
Web-based Resources for Bioterrorism Related Issues.
Week 9 Seminar Protecting Emergency Responders: Lessons Learned From Terrorist Attacks.
Bioterrorism intentional use of harmful biological substances or germs to cause widespread illness and fear.
Presentation 1 Fairen Angelin, Samson M. Sc
Special Acknowledgments
Antibiotics: handle with care!
Working with Biological Hazards
Applying technical requirements of ISO/IEC 17025:2005 in the Zoonotic diseases testing laboratory. Discussion on the challenges M.A Motaung.
This is an archived document.
BSL-1 Laboratory BIOHAZARD
Strategic National Stockpile (SNS)
World Organisation for Animal Health
Public health measures toward prevention
The Alliance is partially funded by grant support from
M-Learning 4 Those Who Care
Presentation transcript:

United States Army Medical Research Institute of Infectious Diseases KYLE MELLING

— Mission —  To provide leading edge medical capabilities to deter and defend against current and emerging biological threat agents — Vision —  To be the leader in the advancement of medical biological defense with world renowned experts dedicated to protecting our military forces and the nation — Core Competencies —  Development, testing and evaluation of medical countermeasures  Providing world-class expertise in medical biological defense  Rapid identification of biological agents  Training and educating the force  Maintaining biosafety, biosurety and biosecurity standards  Preparing for technological uncertainty

Background  Located in Fort Detrick, MD  Established Jan 27, 1969  Core mission is to protect the warfighter from biological threats, but also investigate disease outbreaks and threats to public health.  Most research is done in BSL-3 settings, but one of only 3 labs with BSL-4 clearance in US (fourth is planned)  Biological warfare development banned by Nixon 1969/1970

BSL - 4  Only four BioSafety Levels (1 – 4, with 4 being highest)  Positive-pressurize suits that need routine checks for leaks  Stringent entry and exit procedures such as numerous showers, a vacuum room, an ultraviolet light room, etc.  Used for highly infectious diseases as well as other dangerous and exotic hazards

Operation Whitecoat  A biodefense medical research program carried out by the United States Army between 1954 and 1973  More than 2,300 U.S. Army soldiers volunteered  Exposed to dangerous bacteria that were considered likely choices for a biological attack, or other harmful diseases (encephalitis, hep A, plague, etc)  Vaccines for bioweapons tested, along with other treatment drugs  Treated with antibiotics afterwards to cure infections

More Recently  Over 260,000 tests over next 8 months after 9/11 for “Amerithrax”  Few safety incidences caused heightened measures  Heavily involved in the training of first responders across the world  Offer unique courses ranging from 2 hrs to a week for different biological terror conditions  Construction of adjacent building to USAMRIID to expand

Resources  cold-war-to-present-day/ cold-war-to-present-day/   Army-Medical-Research-Institute-of-Infectious-Diseases.html Army-Medical-Research-Institute-of-Infectious-Diseases.html